Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Tc-99m hexamethylpropylene-amine oxine (HM-PAO) uptake in a bone metastasis

Journal Article · · Clin. Nucl. Med.; (United States)
Uptake of Tc-99m Hexamethylpropylene-amine Oxine (HM-PAO) was seen in bone metastases from carcinoma of the lung. The uptake was prominent when compared to Tc-99m MDP, I-123 IMP, and Ga-67 citrate. Brain imaging with Tc-99m HM-PAO and N-isopropyl-p-(I-123) iodoamphetamine (IMP) is now frequently performed. Uptake of these agents has been reported in brain tumors and melanomas. In this report, uptake of Tc-99m HM-PAO in a metastatic lesion in bone is discussed.
Research Organization:
Miyazaki Medical College (Japan)
OSTI ID:
6543883
Journal Information:
Clin. Nucl. Med.; (United States), Journal Name: Clin. Nucl. Med.; (United States) Vol. 13:8; ISSN CNMED
Country of Publication:
United States
Language:
English